After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Syndax Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Syndax Pharmaceuticals Inc is $963.30M. A total of 1.34 million shares were traded on the day, compared to an average of 2.31M shares.
In the most recent transaction, Botwood Nicholas A.J. bought 11,765 shares of SNDX for 8.99 per share on May 16 ’25. After the transaction, the Head of R&D, CMO now owns 35,165 company shares. In a previous transaction on May 19 ’25, Huber Martin H. Jr. bought 5,000 shares at 8.99 per share. SNDX shares that Director owns now total 79,000.
Among the insiders who bought shares, Katkin Keith acquired of 10,000 shares on May 19 ’25 at a per-share price of $9.11. This resulted in the Director holding 100,000 shares of SNDX after the transaction. In another insider transaction, Metzger Michael A sold 7,814 shares at $15.05 per share on Mar 04 ’25. Company shares held by the Chief Executive Officer now total 300,121.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, SNDX has a high of $25.07 and a low of $8.58.
As of this writing, SNDX has an earnings estimate of -$0.99 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of -$0.87 per share and a lower estimate of -$1.07.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. SNDX’s latest balance sheet shows that the firm has $446.83M in Cash & Short Term Investments as of fiscal 2021. There were $20.97M in debt and $20.68M in liabilities at the time. Its Book Value Per Share was $2.50, while its Total Shareholder’s Equity was $408.37M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SNDX is Buy with a score of 4.86.
